Hearing Dysfunction After Treatment With Teprotumumab for Thyroid Eye disease

Prof. Andrew Anderson from the Department of Optometry & Vision Sciences, Melbourne, Australia presents his recent randomized control trial on the utility of blue blocking lenses.

Dr. David Brown from Retina Consultants of Texas discusses where brolucizumab fits in the treatment paradigm for diabetic macular edema based on two recent phase III trials.

Dr. Audina Berrocal from Bascom Palmer Eye Institute discusses findings from her American Ophthalmological Society Thesis.

Dr. Aaron Lee from the University of Washington shares his insights on deep learning and biobanking as it relates to the current and future landscape of Ophthalmology. He discusses his recent article: "Automated Detection of Glaucoma With Interpretable Machine Learning Using Clinical Data and Multi…